Search for: "Teva Pharmaceuticals USA, Inc."
Results 141 - 160
of 489
Sort by Relevance
|
Sort by Date
7 Mar 2018, 11:52 am
Teva Pharmaceuticals USA, Inc. [read post]
8 Feb 2018, 7:31 am
Teva Pharmaceuticals USA, Inc., February 5, 2018, Stengel, L.). [read post]
2 Feb 2018, 1:31 pm
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
11 Dec 2017, 5:16 pm
The petition of the day is: Teva Pharmaceuticals USA, Inc. v. [read post]
25 Oct 2017, 6:55 am
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
19 Oct 2017, 2:17 pm
TEVA Pharmaceuticals USA, INC. [read post]
19 Oct 2017, 2:17 pm
TEVA Pharmaceuticals USA, INC. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 7:36 am
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED October 16, 2017, Order) (Bryson, CJ) [read post]
16 Oct 2017, 12:36 pm
Teva Pharmaceuticals USA Inc. [read post]
24 Sep 2017, 5:04 pm
Teva Pharmaceuticals USA, Inc. [read post]
29 Aug 2017, 7:35 am
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED August 25, 2017, Order) (Bryson, CJ) [read post]
20 Jul 2017, 12:47 pm
On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
20 Jul 2017, 12:47 pm
On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
17 Jul 2017, 9:41 am
USA,Inc., 752 F.3d 967, 973 (Fed. [read post]
26 Jun 2017, 7:51 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel of Judges Dyk, Mayer and O’Malley determined: “after the AIA, if the existence of the sale is public, the details of the invention need not be publicly disclosed in the terms of sale” for the sale to be invalidating. [read post]
25 Jun 2017, 9:25 pm
District Court for the District of Delaware issued a Memorandum Order that, inter alia, overruled objections by Defendants Glenmark Pharmaceuticals Inc., USA and Teva Pharmaceuticals USA, Inc. to a Report and Recommendation issued by Magistrate Judge Burke and adopted the Report. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
